- Royal Philips Electronics N.v Driver Ed
- Royal Philips Electronics Stock
- Royal Philips Electronics N.v Driver Hub
ST. LOUIS, June 9, 2014 /PRNewswire/ -- Royal Philips (NYSE: PHG AEX: PHIA) today introduced Vereos PET/CT, the first digital PET/CT scanner, at the 2014 annual meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), taking place this week in St. Louis, Mo. In addition to Vereos, Philips will showcase a selection of innovative, molecular imaging solutions designed to deliver outstanding image quality, critical clinical information and greater connectivity.
Stock analysis for Koninklijke Philips NV (PHIA:EN Amsterdam) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Learn more about Philips and how we help improve people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting.
Philips Vereos PET/CT uses innovative digital silicon photomultiplier detectors instead of traditional analog detectors, creating a step change in performance that includes approximately two-times increase in sensitivity gain, volumetric resolution and quantitative accuracy compared to analog systems.* These improvements can ultimately be translated into high image quality, increased diagnostic confidence, improved treatment planning and faster workflows.
'From connected devices toMolecular imaging technology is leading the way with digital detection and advanced visualization built on insights from those at the heart of care.'
Visitors to the Philips Booth (#1521) at SNMMI will have the opportunity to interact with Vereos digital PET/CT clinical images and technology using engaging 3D visualization tools. This unique experience provides clinicians an understanding of how Vereos can be used to deliver customized care to meet their most pressing needs.
During the SNMMI annual meeting, Philips will also host a series of three 'Innovation Talks' in its booth theater area on Monday, June 9. These sessions will spotlight customers, scientists and industry thought leaders who will discuss topics related to the current and future landscape for digital PET, patient-centered imaging, and the importance of creating customized workflows to help manage patient care and radiation dose. Each of the 'Innovation Talks' sessions will last 15 minutes and is open to all event attendees.
In addition to Vereos, Philips will showcase a selection of its advanced molecular imaging technology solutions that help contribute to a 360-degree view of the patient and offer increased diagnostic confidence. Designed to provide access to the right data at the right time, these solutions seamlessly exchange health information data, and interpret the data that matters most to help improve patient outcomes and save lives.
These technologies include:
- iPatient: An advanced platform with an intuitive interface, iPatient helps to facilitate patient-centered imaging, allows for efficient communication between the CT system and injector, and aids in the delivery of appropriate contrast dose and consistent image quality.
- BrightView XCT: A SPECT/CT system designed entirely for nuclear medicine, BrightView XCT enables low patient dose levels, high-resolution localization and high-quality attenuation correction, for smart assessments and short exams with the patient's comfort in mind.
- IntelliSpace Portal: Part of Philips' family of clinical information systems within Philips Healthcare Informatics Solutions and Services Group, the IntelliSpace Portal offers extensive clinical coverage, streamlined workflow and continuous evolution of advanced visualization and analysis capabilities within a single solution.
Royal Philips Electronics N.v Driver Ed
For more information on Philips' presence at SNMMI (Booth #1521), and the full suite of Philips molecular imaging technology solutions, visit www.philips.com/snmmi and follow the #SNMMI14 conversation with @philipshealth.
*GEMINI TF 16
About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 112,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.
SOURCE Royal Philips
Help employers find you! Check out all the jobs and post your resume.
Royal Philips Electronics of the Netherlands is a diversified Health and Well-being company, focused on improving people’s lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of “sense and simplicity”. Headquartered in the Netherlands, Philips employs approximately 116,000 employees in more than 60 countries worldwide. With sales of EUR 23 billion in 2009, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications.
Healthcare
We combine our expertise in medical technology with the clinical know-how of our customers to produce innovative solutions that meet not just the needs of individual patients, but which also enable healthcare professionals to work faster, more easily and more cost-effectively. Our medical customers have ranked us number 1 in cardiovascular X-ray, digital X-ray and ultrasound, patient monitoring systems, nuclear medicine, cardiology systems and critical care systems.
Healthcare Information Management
The department Healthcare Information Management of Philips Research Europe focuses on Information Management in Clinical Applications and in Home Care environments and on Clinical Decision Support Systems. The two main clinical domains currently addressed are oncology and cardiology, next to generic solutions regarding clinical information systems, information integration, domain modelling, medical imaging, standardization and interoperability. Beside carrying out industrial research projects for Philips Healthcare, the members of the group have participated in and led numerous collaborative projects at National (Dutch-government funding) and European level.
In CHIC, Philips will be working alongside other partners in WP2, WP5 and WP10 on the user requirement engineering, the architectural design of the CHIC system, its computational infrastructure, the design of the model repositories and the system’s interoperability. Moreover, Philips will contribute to the project’s exploitation strategy and dissemination of project results.
Team members
AncaBucurRoyal Philips Electronics Stock
Royal Philips Electronics N.v Driver Hub
Email